drugset / Trial / NCT00226499

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

NCT00226499

Phase 3 Completed 5803 enrolled GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindPrevention

Summary

An observer-blind study to evaluate GlaxoSmithKline Biologicals' live attenuated varicella vaccine and GlaxoSmithKline Biologicals' combined measles-mumps-rubella-varicella vaccine in the prevention of varicella disease in children. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Timeline

Start
2005-09-01
Primary completion
2006-10-12
Completion
2006-10-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Priorix Vaccine Subcutaneous
Subject Priorix-Tetra Vaccine Subcutaneous
Subject Varilrix Vaccine Subcutaneous

Indications